|
WebMD Health - Multiple Sclerosis
|
WebMD Health - Trustworthy, Credible and Timely Health Information
|
|
-
Active Mind May Protect MS Patients
A small study of multiple sclerosis (MS) patients shows that maintaining an intellectually active lifestyle can help preserve learning and memory, even among patients who had high amounts of brain damage.
-
FDA Panel Votes to Approve Gilenia, First Oral MS Drug
An FDA panel today overwhelmingly voted to approve Novartis's Gilenia, the first oral drug for multiple sclerosis. Gilenia has serious side effects; patients must be closely monitored.
-
Survey Reveals Economic Toll of MS
All over the world, almost half of people with multiple sclerosis (MS) quit work within three years of being diagnosed with the debilitating disease, a new survey shows.
-
Multiple Sclerosis: Advances in Research and Treatment
While the cause of multiple sclerosis or MS is still not known, recent advances in treatments and new understanding about the disease offer great hope for the near future, researchers say.
-
Caution Urged for Experimental MS Treatment
People with multiple sclerosis (MS) should not undergo a controversial new treatment that's based on the theory that blocked neck veins can trigger MS, experts say.
-
Experimental MS Drug Outperforms Standard Treatment
Nearly 71% of people with early relapsing-remitting multiple sclerosis (MS) treated with the an experimental MS drug showed no evidence of disease activity four years into a study, researchers report.
-
Statin Drugs Show Some Promise for Multiple Sclerosis
Statin drugs such as Lipitor show promise for the treatment of multiple sclerosis, a small, preliminary study suggests.
-
Two Types of MS?
Study: There appear to be two types of multiple sclerosis -- and simple blood test may soon tell people which type they have and whether beta interferon treatment will work.
-
Clay Walker Raises Money for Multiple Sclerosis
Country music star Clay Walker's MS is in remission, but he helps educate the public about the disease and raises funds for a cure.
-
MS Drug Ampyra Gets FDA Nod
The FDA has approved Ampyra (dalfampridine), which improves walking ability in MS patients. Ampyra is taken with other MS drugs and does not keep MS from getting worse.
-
Marijuana Eases Spasticity in MS Patients
Marijuana extracts may reduce spasticity symptoms in people with multiple sclerosis, a new study shows.
-
Childbirth May Slow Progression of MS
Childbirth appears to slow the progression of multiple sclerosis, whether a woman gives birth before her diagnosis or after, according to a Belgian study
-
No Increased Pregnancy Risk for MS Patients
Pregnant women with multiple sclerosis (MS) are only a little more likely to deliver babies by cesarean section than their counterparts who don't have the neurological disorder, a new study shows.
-
Teenage Obesity May Raise Risk of MS
Obesity in adolescent girls may increase the risk for multiple sclerosis later in life, a study shows.
-
Marker May Predict Multiple Sclerosis Severity
A newly identified biomarker may be linked to the severity of multiple sclerosis and may one day help with diagnosis and treatment of the often frustrating and unpredictable disease.
-
FDA Panel: New MS Drug Helps Walking
Ampriva helps some multiple sclerosis patients walk better, an FDA advisory panel says. The finding makes it more likely that full FDA approval will come soon.
-
Multiple Sclerosis: Questions to Ask Your Doctor
Early treatment can reduce the severity of this debilitating illness. The key? Don’t wait for symptoms to progress
-
When MS Attacks
Here's the latest on fighting flare-ups of multiple sclerosis.
-
Multiple Sclerosis: The Importance of Early Treatment
Information about the importance of early detection of symptoms and treatment for multiple sclerosis.
-
Blood Pressure Drug May Help Treat MS
A drug commonly used to treat high blood pressure may also double as a multiple sclerosis treatment.
|
WebMD by Topic 
